Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
27.98
+1.15 (4.29%)
At close: Nov 6, 2026, 4:00 PM EST
27.51
-0.47 (-1.68%)
After-hours: Nov 6, 2026, 7:30 PM EST

Adaptive Biotechnologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
298.01276.98178.96170.28185.31154.34
Revenue Growth
17.90%54.77%5.10%-8.11%20.06%56.88%
Gross Profit
137.8111.853.92-27.39-14.36-37.3
Operating Income
-48.21-57.12-155.34-201.61-200.19-208.97
Net Income
-70.52-59.5-159.49-225.25-200.19-207.28
Earnings Per Share
-0.45-0.39-1.08-1.56-1.40-1.48
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Minimal Residual Disease (MRD)
267.71212.33145.53102.7487.14
Immune Medicine
30.364.6433.4367.5498.16
Total
298.01276.98178.96170.28185.31

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
400.18240.21255.95346.4498.2570.21
Total Debt
408.97210.36222.67229.43233.36111.74
Net Cash (Debt)
-8.7929.8633.29116.97264.83458.47
Net Cash Growth
--10.30%-71.54%-55.83%-42.23%-34.41%
Net Cash Per Share
-0.060.200.230.811.863.27

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.28-45.99-95.21-156.32-183.95-192.73
Capital Expenditures
-4.55-2.96-3.66-10.7-16.35-61.75
Free Cash Flow
-8.82-48.95-98.88-167.02-200.29-254.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.24%40.38%2.19%-16.09%-7.75%-24.17%
Operating Margin
-16.18%-20.62%-86.80%-118.40%-108.03%-135.39%
Pretax Margin
-23.73%-21.47%-89.18%-132.32%-108.13%-134.31%
Profit Margin
-23.66%-21.48%-89.12%-132.28%-108.03%-134.30%
FCF Margin
-2.96%-17.67%-55.25%-98.09%-108.09%-164.87%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.208.954.944.175.9025.66